NCT04793984View on ClinicalTrials.gov

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

July 30, 2022

Conditions
Covid19
Interventions
DEVICE

Carragelose

inhalation 3 times a day

DEVICE

NaCl

inhalation 3 times a day

Trial Locations (1)

1210

Gesundheitsverbund, Klinik Floridsdorf, Vienna

Sponsors
All Listed Sponsors
lead

Marinomed Biotech AG

INDUSTRY

NCT04793984 - Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients | Biotech Hunter | Biotech Hunter